Although more than 100 mutations have been identified in the copper/zinc superoxide dismutase (Cu/Zn-SOD) in familial amyotrophic lateral sclerosis (FALS), the mechanism responsible for FALS remains unclear. The finding of the present study shows that FALS-causing mutant Cu/Zn-SOD proteins (FALS mutant SODs), but not wild-type SOD, are barely detected by three monoclonal antibodies (mAbs) in Western blot analyses. The enzyme-linked immunosorbent assay for denatured FALS mutant SODs by dithiothreitol, SDS, or heat treatment also showed a lowered immunoreactivity against the mAbs compared with wild-type SOD. Because all the epitopes of these mAbs are mapped within the Greek key loop (residues 102-115 in human Cu/Zn-SOD), these data suggest that different conformational changes occur in the loop between wild-type and FALS mutant SODs during the unfolding process. Circular dichroism measurements revealed that the FALS mutant SODs are sensitive to denaturation by dithiothreitol, SDS, or heat treatment, but these results do not completely explain the different recognition by the mAbs between wild-type and FALS mutant SODs under the denatured conditions. The study on the conformational changes in local areas monitoring with mAbs may provide a new insight into the etiology of FALS.
Amyotrophic lateral sclerosis (ALS)
1 is a neurological disease characterized by selective motor neurons in the brain and spinal cord. Although most reported cases are sporadic ALS, 5-10% are familial ALS (FALS). About 20 -25% of FALS cases have been shown to be associated with mutations in the copper/ zinc superoxide dismutase (Cu/Zn-SOD) gene, SOD1 on chromosome 21q22.1 (1, 2) . Cu/Zn-SOD is a homodimer containing one copper ion and one zinc ion in each 16-kDa subunit. Cu/ Zn-SOD catalyzes the disproportionation of superoxide anion (O 2 . ) into O 2 and H 2 O 2 and has been shown to play a protective role in cells against oxidative stress. To date, more than 100 FALS-causing mutations in the Cu/Zn-SOD, which consists of 153 amino acids, have been identified (3) . Although some FALS causing-mutant Cu/Zn-SOD proteins (FALS mutant SODs) show less enzymatic activities, many retain full activity (4) . Several lines of transgenic mice that express mutant human SOD1 linked with FALS developed progressive neurodegeneration and a phenotype that clearly resembles human FALS (5, 6) despite having higher SOD activity. In contrast, SOD1-knock out mice do not exhibit motor neuron dysfunction (7) . These findings suggest that this disease is the result of a toxic gain of function but not a loss in SOD activity. Several different hypotheses have been proposed to explain the toxic gain of function, including the production of ROS, mitochondrial defects, glutamate-induced excitotoxicity, neurofilament inclusions, and the formation of intracellular toxic protein aggregates (reviewed in Ref. 8) . However, the mechanism by which FALS mutant SODs causes motor neuron degeneration is not completely understood.
The tertiary structure of Cu/Zn-SOD is characterized by the presence of a Greek key ␤-barrel containing an internal disulfide bond between Cys-57 and Cys-146 (9, 10), both of which contribute to its high stability. On the other hand, various FALS mutant SODs show a decreased stability and a lower level of metallation (4, 11, 12) . Several reports, including ours ( Fig. 1) , 2 reported that FALS mutant SODs exhibit an accelerated turnover or an increased susceptibility to degradation in proteasome (13, 14) and suggest that unfolding or conformational perturbations of mutant SOD proteins occur in vivo. Niwa et al. (15) reported that Dorfin, a RING finger-type ubiquitin-protein isopeptide ligase (E3) ubiqutinates the FALS mutant SODs but not wild-type Cu/Zn-SOD, suggesting that FALS mutant SODs have a unique structure that can be recognized by Dorfin. We reported previously that FALS mutant SODs are more susceptible to glycation or fructation (16) and that they form aggregates at a higher rate than the wild-type SOD, when incubated in the presence of copper ions (4) . These data also indicate that FALS mutant SODs are susceptible to conformational changes. Inclusion bodies or aggregates that are immunoreactive to Cu/Zn-SOD were also observed in motor neurons and astrocytes of mice expressing mutant SOD1, as well as in human ALS cases linked to SOD1 (17, 18) . It has been reported recently that purified FALS mutant SODs also have a propensity to aggregate or to form amyloid-like fibrils (19 -22) . Therefore, it is possible that the pathology of FALS associated with mutant SODs may also involve aggregate formation and the degeneration of neuronal cells analogous to other neurodegenerative disorders such as Alzheimer's, Parkinson's, and Huntington's diseases, prion encephalopathies, and cystic fibrosis. Although it is generally thought that aggregation and amyloid formation require a conformational transition in a polypeptide chain from a native form to an improperly folded or mis-folded conformation in these diseases, the molecular basis of this remains unclear (23) .
A monoclonal antibody (mAb) is a good tool for detecting structural differences and conformational changes in local areas within a protein molecule. A conformational transition of the prion protein has been detected by various mAbs (24 -26) . The pH-dependent conformational transition of the Alzheimer ␤-amyloid peptide was monitored by their mAbs (27) . Inhibition of the fibrillar aggregation of the Alzheimer ␤-amyloid peptide (28) and inhibition of prion transmission (29) have also been reported, based on the use of mAbs.
The findings in the present study show that unfolded FALS mutant SODs show a lower immunoreactivity against three mAbs, compared with unfolded wild-type Cu/Zn-SOD in Western blots and ELISA. The epitope for all the mAbs was determined to be located in the Greek key loop VI. These data suggest that the denatured forms in this local area might well be different between wild-type and FALS mutant SODs because variations in recognition by the mAbs may indicate structural differences at this loop. This is the first demonstration of different recognition by mAbs between wild-type and FALS mutant SODs. The use of mAbs as a microprobe promises to contribute to the clarification of the structural mechanism by which FALS mutant SODs cause ALS.
EXPERIMENTAL PROCEDURES
Antibodies-Monoclonal antibodies against human Cu/Zn-SOD, N6, and SD-G6 were purchased from Panafarm (Kumamoto, Japan) and Sigma, respectively. 5c-10 was kindly provided by Dr. Uda (Hiroshima Prefecture University). Horseradish peroxidase-conjugated rabbit antigoat IgG and goat anti-rabbit IgG were purchased from Dako (Denmark). Horseradish peroxidase-conjugated rabbit anti-mouse IgG was obtained from Promega. Picotan/picotein rabbit anti-DNP (IgG) was purchased from Cosmobio (Japan).
Cell Culture and Expression of Wild-type and Mutated Cu/Zn-SOD in Mammalian Cells-Neuro2a, a murine neuroblastoma cell line, was maintained in Dulbecco's modified Eagle's medium containing 100 units/ml penicillin and 100 g/ml streptomycin supplemented with 10% heat-inactivated fetal bovine serum (Invitrogen) at 37°C under an atmosphere of 95% air and 5% CO 2 . Cells were transfected with the following wild-type and mutated SOD1 cDNAs transiently by Lipofectamine 2000, according to the manufacturer's instructions. The culturing of Spodoptera frugiperda (Sf21) cells and manipulations of the baculovirus were performed according to the procedures described by Piwnica-Worms (30) . Sf21 cells were maintained in Grace's medium containing 3.3 mg/ml yeastolate, 3.3 mg/ml lactalbumin hydrolysate, and 50 g/ml gentamycin supplemented with 10% heat-inactivated fetal bovine serum at 27°C.
Mutagenesis and Construction of Plasmids-Point mutations were introduced into the human SOD1 cDNA in Bluescript SK(ϩ) using the overlap extension PCR mutagenesis procedure (31) . The wild-type and mutant cDNAs were transferred into the pcDNA3.1 mammalian expression vector and pVL1393 baculovirus expression vector between the BamHI and NotI sites. These constructs were confirmed by an automated DNA sequencing (Applied Biosystems model 310).
Western Blot Analysis-Proteins were subjected to SDS-PAGE and then transferred to a nitrocellulose membrane under semi-dry conditions by means of a Trans-blot (Bio-Rad). After blocking by incubation with 4% skim milk in Tris-buffered saline (20 mM Tris-HCl, pH 8.0, 0.15 M NaCl (TBS)) for 12 h at 4°C, the membrane was incubated with a goat polyclonal antibody or monoclonal antibodies against human Cu/Zn-SOD (1000 ng/ml) in Tris-buffered saline containing 0.05% Tween 20 (TBS-T) and containing 1% skim milk for 2 h at room temperature.
After washing with TBS-T, the membrane was incubated with peroxidase-conjugated rabbit anti-goat IgG (diluted 1:5000 in TBS-T containing 1% skim milk) or rabbit anti-mouse IgG (diluted 1:5000 in TBS-T containing 1% skim milk) for 2 h. After washing, the chemiluminescence method using an ECL kit (Amersham Biosciences) was employed to detect the peroxidase activity.
Overproduction and Purification of Wild-type and Mutant Cu/Zn-SOD Proteins-For the overproduction of Cu/Zn-SODs by the baculovirus/insect cells system, the wild-type cDNA and mutant cDNAs were ligated into the baculovirus transfer vector pVL1393 (Invitrogen) and cotransfected with BaculoGold (Pharmingen) into Sf21 cells using Lipofectin (Invitrogen). 0.5 mM CuCl 2 and 0.5 mM ZnCl 2 were added directly to the medium after viral infection. Purification of SOD proteins that were overproduced in Sf21 cells was carried out essentially as described previously (16) with minor modifications. 1-4 ϫ 10 8 infected Sf21 cells were harvested and washed with PBS(Ϫ) and stored at Ϫ20°C until used. The cells were homogenized in buffer A (2.5 mM potassium phosphate, pH 7.4) containing protein inhibitor mixture without EDTA (Roche Applied Science) and centrifuged at 100,000 ϫ g for 30 min. The supernatant was applied to a DE52 cellulose column. After washing with buffer A, the bound proteins were eluted with a linear gradient of potassium phosphate from 2.5 to 200 mM. Fractions containing SOD protein were dialyzed on a PD10 column with buffer B (10 mM potassium phosphate, pH 7.4). The fractions were applied to a MonoQ-Sepharose column (Amersham Biosciences). After washing with buffer B, the bound proteins were eluted with a linear gradient of KCl (0 -100 mM) in buffer B. Fractions containing SOD protein were dialyzed on a PD10 column with buffer C (10 mM potassium phosphate, pH 6.8) and applied to a hydroxyapatite type I column (Bio-Rad) to eliminate the minor contaminated proteins. After washing with buffer C, the bound proteins were eluted with a linear gradient of potassium phosphate from 10 to 300 mM. Fractions containing SOD protein were dialyzed on a PD10 column with 50 mM sodium bicarbonate, pH 9.6, and concentrated by Microcon YM-10 (Millipore). The MonoQ-Sepharose column and the hydroxyapatite column chromatography works were performed using AKTA Explorer 10S (Amersham Biosciences). The purity of SOD proteins was more than 99%, as judged by SDS-PAGE.
ELISA-Purified Cu/Zn-SOD proteins (0.25 mg/ml), with and without denaturing treatments in coating buffer (50 mM sodium bicarbonate, pH 9.6), were diluted to 1 g/ml with coating buffer. 100 l of the samples were added to each well of 96-well microplates (Maxisorp, Nunc), incubated overnight at 4°C, washed three times with PBS containing 0.01% Tween 20 (PBS-T), and then blocked for 2 h at room temperature with 1% BSA in PBS. The plates were then washed three times with PBS-T, and 100 l of monoclonal and goat polyclonal antihuman Cu/Zn-SOD antibodies (desired dilution in PBS-T) was added, followed by incubation for 1 h at room temperature. The plates were washed three times with PBS-T, and 100 l of horseradish peroxidaseconjugated anti-mouse IgG (diluted 1:5000 in PBS-T) for monoclonal antibodies, anti-goat IgG (diluted 1:5000 in PBS-T) for a goat polyclonal antibody, or anti-rabbit IgG (diluted 1:5000 in PBS-T) for a rabbit polyclonal antibody was added and incubated for 1 h at room temperature. After washing five times with PBS-T, the plates were developed using 100 l of o-phenylenediamine dihydrochloride solution, and the reaction was stopped with 25 l of 2 M HCl. The absorbance of each well was determined at 490 nm with an Immunoreader NJ 200 (Intermed).
Preparation of DNP-SODs and Its ELISA-Preparation of DNPSODs was performed according to a previous report by Little and Eisen (32) and the manufacturer's protocol of Picotan/picotein rabbit anti-DNP with minor modifications. Briefly, purified Cu/Zn-SOD proteins (0.25 mg/ml) were mixed with an equal volume of 2,4-dinitrobenzenesulfonyl chloride (DNBS) (1 mg/ml) in 0.5 M Na 2 CO 3 , pH 11.5, which had been incubated for 2 h at 37°C, and diluted to various concentrations (0.05-1 g/ml) in coating buffer. 100 l of the samples were added to each well of 96-well microplates and incubated overnight at 4°C. After washing, Picotan/picotein rabbit anti-DNP in PBS-T was directly added to the wells without a blocking step. The other steps were performed according to the method described above.
CD Analyses-Purified Cu/Zn-SOD proteins with and without denaturing treatments in coating buffer were subjected to CD spectral measurement using a Jasco J-720 spectropolarimeter (Jasco, Japan).
The secondary structure was monitored over the wavelength range of 200 -250 nm using a 0.1-cm path length cuvette at 25°C. Eight scans were averaged for each sample; the averaged blank spectra of detergents dissolved into the same buffer solutions were subtracted. The CD data were expressed as mean residue ellipticity [] (degree cm 2 /dmol). The protein concentrations under the CD measurements were 15 M.
Epitope Mapping-0.5 mg of WT and A4V proteins were incubated at 0.25 mg/ml in 50 mM Tris-HCl, pH 8.6, containing 5 mM DTT, 7 M guanidine HCl, and 10 mM EDTA at 37°C for 2 h. The free sulfhydryls were carboxymethylated by adding iodoacetic acid in the dark at room temperature for 30 min. After dialysis on a PD10 column with 50 mM Tris-HCl, pH 9.0, the proteins were digested with 0.25% (w/w) lysyl endopeptidase (Wako Pure Chemicals) at 37°C for 16 h. The resulting peptides were applied to a reverse phase HPLC (AKTA Explorer 10S) at a flow rate of 1 ml/min on a Sephacryl peptide C18 column (4.6 ϫ 250 mm, Amersham Biosciences). The peptides were separated by a linear gradient of 2-50% acetonitrile containing 0.05% trifluoroacetic acid. Peptides were detected by their absorbance at 215 nm. The peaks were subjected to mass spectrometry, amino acid sequencing, and ELISA. For the ELISA, the separated peptides or synthesized peptides were diluted with PBS(Ϫ), added to 96-well plates, and incubated for 2 h at room temperature. After washing, the first antibodies (mAbs) in PBS-T were directly added to the wells without a blocking step. The other steps were performed according to the method described above. Synthesized peptides were purchased from Sigma Genosys.
Protein Assay-Protein concentrations of crude samples were determined by using a protein assay kit (Bio-Rad) with bovine serum albumin as a standard. Purified Cu/Zn-SOD protein concentrations were estimated using a dimeric molar extinction at 280 nm of 10,800 M Ϫ1 cm Ϫ1 (33) .
RESULTS

Typical FALS Mutant SODs Are Susceptible to Degradation in Neuro2a
Cells-Mutant SOD1 cDNAs, A4V, G37R, H46R, G93A, and C111S were obtained using wild-type (WT) human SOD1 cDNA. The mutant C111S is not found in FALS, and Ser-111 is conserved in Cu/Zn-SOD in other mammalian species except for humans. It has also been reported that C111S is more thermally stable than the wild type (34, 35) . Therefore, it would be expected that C111S does not cause ALS and can be used as a second control (wild type).
These mutant cDNAs, as well as the wild-type cDNA, were transiently transfected into Neuro2a cells. As shown in Fig. 1 , although all human Cu/Zn-SOD proteins expressed the similar levels 24 h after transfection, A4V, G37R, and G93A were degraded more rapidly than H46R 48 h after transfection. The stability of the C111S protein was comparable with the wild type (WT), and both were more stable than the H46R protein.
Endogenous mouse Cu/Zn-SOD was unchanged through the period of this observation. The addition of MG132, proteasome inhibitor, 24 h after transfection restored the protein levels of A4V, G37R, and G93A in a concentration-dependent manner (data not shown), which is consistent with previous studies (13, 14) . In addition, Ratovitski et al. (36) have reported that H46R has longer half-life than other FALS mutant SODs in cells by 35-S pulse-chase. We have also obtained similar results that the half-lives of A4V, G37R, and G93A were shorter than H46R (data not shown). Therefore, Fig. 1 suggests that FALS mutant SODs have the propensity to be degraded in the proteasome and that H46R is longer lived than other FALS mutant SODs in cells.
Typical FALS Mutant SODs Are Barely Detected by Monoclonal Antibodies in Western Blot
Analyses-We used monoclonal antibodies against human Cu/Zn-SOD (mAbs N6 and SD-G6) to detect expressed human Cu/Zn-SOD proteins in the cell lysate 24 h after transfection. As shown in Fig. 2A , WT and C111S were detected by both mAbs, and H46R was detected by mAb N6 slightly. However, A4V, G37R, and G93A were not detected by both mAbs ( Fig. 2A) , even though all proteins were detected at the same level by a polyclonal antibody (Fig. 1, 24 h ).
To analyze further in detail the lowered reactivity of the FALS mutant proteins with these mAbs, purified Cu/Zn-SOD proteins were subjected to Western blot analyses. As shown in Fig. 2B , typical FALS mutant SODs, A4V, G37R, and G93A, were scarcely detected by these mAbs, as well as by a third monoclonal antibody, mAb 5c-10. In contrast, H46R was detected by all mAbs to a greater extent than the other FALS mutant SODs, and C111S and WT reacted much more strongly with all mAbs. Each of the nitrocellulose membranes after 
FIG. 2. Western blot analyses of wild-type and mutant SODs detected by monoclonal antibodies.
A, human (h) Cu/Zn-SOD expressed in Neuro2a cells at 24 h after the transfection was detected by Western blot analyses using monoclonal antibodies. B, 30 ng of purified wild-type and mutant SODs were subjected to SDS-PAGE and were detected by Western blotting using monoclonal antibodies. Each nitrocellulose membrane, after reacting with the monoclonal antibodies, was de-probed by treatment with stripping buffer and re-incubated with a polyclonal antibody, and representative data are shown.
reacting with the mAbs was de-probed by treatment with a stripping buffer (80 mM Tris-HCl, pH 6.8, containing 2.5% SDS, 1% 2-ME) and re-incubated with a polyclonal antibody. Representative results show that the same amounts of Cu/Zn-SOD proteins are present on the membrane. These results clearly show that typical FALS mutant SODs are barely recognized by the monoclonal antibodies in Western blot analyses despite having only one amino acid replacement.
ELISA for Denatured SODs Showed Results Similar to Western Blotting, although ELISA for Native SODs Did Not-We next examined the reactivity of the purified Cu/Zn-SOD proteins with these mAbs by means of ELISA. Unexpectedly, mAbs 5c-10 and SD-G6 recognized native A4V much stronger than other proteins, and mAb N6 recognized native A4V and H46R strongly (Fig. 3A) , which is inconsistent with the Western blot results. Thus we performed ELISA for proteins after the treatments in the same manner in Western blotting. The SOD proteins were boiled with 2% 2-ME and 2% SDS for 5 min, diluted with coating buffer (50 mM NaHCO 3 , pH 9.6) by 200-fold, and then subjected to ELISA. As shown in Fig. 3B , the treated WT, H46R, and C111S reacted with all the mAbs much more strongly than typical FALS mutant SODs. The reactivity of A4V to these mAbs was drastically decreased by this treatment. All of the treated proteins had almost the same reactivity with the polyclonal antibody. These results were very similar to the results obtained in the Western blot analyses.
All Epitopes of mAbs N6, 5c-10, and SD-G6 Are Located in the Greek Key Loop VI-The question arises as to which region of the human Cu/Zn-SOD is recognized by these monoclonal antibodies. Because there is no map of their epitopes, we performed epitope mapping for these mAbs, N6, 5c-10, and SD-G6. WT was digested with lysyl endopeptidase, and the digest was fractionated by HPLC on a Sephacryl C18 column (Fig. 4A) . Although three peptides, 1-3, 4 -9, and 129 -136 were lost, the peptides corresponding to nine peaks from 1 to 9 were identified as residues 71-75, 123-128, 24 -30, 76 -91, 71-91, 31-36, and137-153, a mixture of 10 -23, 37-70, and 92-122, respectively, as shown in Fig. 4B , by amino acid sequencing and mass spectrometry analyses. These peptides were diluted 10-fold with PBS(Ϫ) and subjected to ELISA. Only one peptide in peak 9, which corresponds to residues 92-122, reacted with all the mAbs (Fig. 4C) . On the other hand, the polyclonal antibody reacted with peptides in peaks 5 and 7-9. The ELISA of peptides from digested A4V also showed the same results. To further identify the epitope for each mAb, the synthesized peptides were subjected to ELISA. As shown in Fig. 4D (a and  b) , peptide 102-116 reacted strongly with all the mAbs and the polyclonal antibody. Moreover, because residues 102-114 and 103-116 did not react with all the mAbs and the polyclonal antibody (Fig. 4D (c) ), we conclude that epitopes of these mAbs are located within residues 102-115. These results clearly indicate that Ser-102 and Arg-115 are essential for binding to all the mAbs and the polyclonal antibody. Epitopes of the mAbs and polyclonal antibody may be composed of Ser-102 and Arg-115 and some residues between Val-103 and Gly-114. The residues 102-115 corresponds to Greek key loop VI between ␤-sheet 4f (residues 94 -101) and ␤-sheet 7g (residues 116 -120) in the tertiary structure of human Cu/Zn-SOD (Fig. 4E,  red line) . It is interesting to note that the epitopes of all mAbs are located in the same region even though they were obtained from different sources, suggesting that this loop may be a strong antigenic region in Cu/Zn-SOD. However, epitopes of the three mAbs are not identical and have different characters. N6 reacts with native A4V and H46R strongly ( Fig. 3A) and does not react with native and denatured G37R well (Figs. 5-7 ), even at higher concentrations (data not shown). 5c-10 and SD-G6 recognize native A4V much stronger than other mutant SODs (Fig. 3A) and does not react with native H46R well.
DTT Treatment Causes Clear Differences in Immunoreactivity against mAbs between Wild-type-like Proteins and FALS
Mutant Cu/Zn-SOD Proteins-Because SDS-PAGE and Western blot analyses includes a reduction with 2-ME, denaturation with SDS, and heating, we investigated the influence of each unfolding treatment on the immunoreactivity of these SOD proteins against mAbs. These SOD proteins were first treated with various concentrations of DTT in the coating buffer for 40 min and then subjected to ELISA. As shown in Fig. 5 , the immunoreactivities of A4V, G37R, and G93A against all mAbs decreased after treatment with DTT at concentrations above 1 mM. On the other hand, the immunoreactivities of WT, C111S, and H46R toward all the mAbs increased at the same concentration of DTT. These data suggest that the denaturation by DTT causes clear opposite tendencies between typical FALS mutant SODs (A4V, G37R, and G93A) and wild-type like proteins (WT, C111S, and H46R), and may contribute to the differences of the recognition by mAbs in Western blot analyses. The rationale for including H46R in this group is described under the "Discussion."
SDS Treatment Affects the Immunoreactivity of SODs against mAbs-
The effect of SDS treatment on reactivity against the mAbs was also monitored. SOD proteins were treated with various concentrations of SDS for 40 min, diluted 200-fold with the coating buffer, and then subjected to ELISA. As shown in Fig. 6 , the immunoreactivity of both WT and mutant proteins against mAb 5c-10 and mAb SD-G6 decreased after incubation with 0.01-0.1% SDS. The reactivity of WT, C111S against 5c-10 increased only after incubation with 2% SDS. On the other hand, the reactivity of WT, C111S, and H46R against mAb N6 was increased after incubation with 1-2% SDS, whereas the reactivity of the typical FALS mutants (A4V, G37R, and G93A) decreased against all the mAbs in an SDS concentration-dependent manner.
Heat Treatment also Affects the Immunoreactivity of SODs against mAbs-Finally, the SOD proteins were incubated at various temperatures in coating buffer for 5 min by using thermal circler (Takara Bio), diluted 200-fold with the coating buffer, and then subjected to ELISA. As shown in Fig. 7 , the immunoreactivity of FALS mutant SODs toward all mAbs decreased with increasing treatment temperature until 70°C. However, the reactivity of WT and C111S against mAb N6 was drastically increased at 80 and 90°C, respectively. The reactivity of H46R against N6 but not 5c-10 or SD-G6 was also maintained at higher temperatures. The reactivity FIG. 4 . Epitope mapping of monoclonal antibodies. A, wild-type SOD was digested with lysyl endopeptidase, and the digest was fractionated by HPLC using a Sephacryl C18 column. B, peptide mapping of human Cu/Zn-SOD. Numbers beside the boxes and numbers above the amino acids show the peak number in A and amino acid residue number, respectively. C, ELISA for the separated peptides. D, ELISA for synthesized peptides. Peak 9 (92-122) was divided into three peptides. a, each peptide consists of 11 or 9 amino acids. b, each peptide consists of 15 or 12 amino acids. c, peptides from which one or two amino acids were deleted (102-116) (b). E, epitope of the mAbs was indicated as red lines on the tertiary structure of A4V Cu/Zn-SOD (Protein Data Bank code 1N19).
of all the SODs against SD-G6 decreased with increasing treatment temperature.
The Different Immunorecognition by mAbs between Wild-type and FALS Mutant SODs Is Not Due to a Different Binding
Efficiency to ELISA Plate-A question may arise as to whether the different recognition by mAbs on ELISA (Figs. 5-7 ) is because of a differential coating efficiency between WT and mutant SODs on the ELISA plate or a different mAbs recognition itself. However, the protein levels on the plate were too low to be measured by authentic protein assay. Stable dinitrophenylated (DNP) protein is easily obtained by incubation with DNBS in alkaline pH solution (32) . Because Picotan/picotein rabbit anti-DNP can react with the DNP proteins of the order of picogram, but not free DNP, we used this system to examine the coating efficiency. Purified SODs were treated with DNBS, diluted to various concentrations (0.05-1 g/ml) in coating buffer, and coated on the ELISA plates. As shown in Fig. 8A , Picotan/picotein rabbit anti-DNP detected all DNP-SODs in the same degree, although the reaction with DNP-C111S was slightly lower. On the other hand, mAb N6 reacted with DNP-C111S strongly and with DNP-WT and DNP-A4V moderately (Fig. 8B) , even though mAb N6 recognized native A4V and H46R strongly (Fig. 3A) . To examine further whether the dinitrophenylation of SODs affects the immunorecognition by mAb N6 or not, SODs were treated with the same conditions in the absence of DNBS and detected by mAb N6 (Fig. 8C) . The similar results in Fig. 8, B and C, indicate that the dinitrophenylation of SODs does not affect immunoreactivity of mAb N6. The treatment at 37°C in alkaline solution would lead a partial denaturation of SODs. These data could exclude the possibility that a differential coating efficiency between WT and mutant SODs on the ELISA plate causes the different ELISA signal.
CD Analyses Showed That FALS Mutant SODs, Especially H46R and A4V, Are Susceptible to Denaturation by DTT, SDS,
and Heat Treatment-The effects of these unfolding treatments, such as DTT, SDS, and heat treatment, on the secondary (whole) structure of SOD proteins were assessed by CD measurements. The spectra of all of the SODs were almost the same for the native state, although H46R showed a slightly different spectrum (Fig. 9A) . These SODs, in coating buffer, were reduced with various concentrations of DTT for 40 min and then subjected to CD analysis. 0.1 mM DTT began to induce small denaturation in H46R, A4V, and G93A (Fig. 9B) , and all the FALS mutant SODs, except WT and C111S, were denatured by 1 mM DTT treatment (Fig. 9C) . The reduced FALS mutant SODs showed a larger negative band at about 202 nm, an increased negative ellipticity from 220 to 240 nm, and a less negative band in the 215 nm region, which indicates an increased random coil/unordered structure and a decreased ␤-structure.
We next examined the effect of SDS on the structure of these proteins. As shown in Fig. 9D , treatment with 2% SDS caused a loss of secondary structure in only H46R and A4V but not in WT, C111S, G37R, and G93A. The structure of H46R and A4V began to change by treatment with SDS at concentrations above 0.05% (data not shown). The CD profiles showed more helical conformation as reported for monomeric Escherichia coli Cu/Zn-SOD treated with SDS at concentrations above 10% (37) , which are quite different from the form produced by reduction with DTT (Fig. 9C) . These data indicate that only H46R and A4V are quite sensitive to SDS and that a propensity toward denaturation by SDS is not common among FALS mutant SODs.
Finally, all SODs that were boiled in the coating buffer for 5 min were subjected to CD analyses. As shown in Fig. 9E , the CD spectra of all proteins were identical, even though differences in immunoreactivity between wild-type SOD and FALS mutant SODs, when treated at over 80 or 90°C, were detected by ELISA for mAb N6 and mAb 5c-10 ( Fig. 7) . Because the CD spectra patterns also showed lower ellipticity from 220 to 240 nm as well as the reduced FALS mutant SODs (Fig. 9C) , we monitored the transition curves of these proteins at 25-70°C at a wavelength of 230 nm. H46R and A4V began to denature at a lower temperature, indicating that both are much more thermolabile than the other SODs (Fig. 9F) . These results indicate that FALS mutant SODs, especially H46R and A4V, are susceptible to denaturation by DTT, SDS, and heat treatment.
DISCUSSION
Although there is some evidence to show that the FALS mutant SODs have a toxic gain of function, the mechanism responsible of this pathology is unknown. Finding the differences of properties between wild-type and FALS mutant SODs and the common characteristics of FALS mutant SODs will give clues to solve the etiology of FALS. The findings here show that typical FALS mutant SODs, but not wild-type SOD, are barely recognized by three monoclonal antibodies in Western blot analyses and ELISA after denaturation, which were in parallel with their degree of increased biological turnover of FALS mutants. Because the epitopes of the three mAbs were mapped within residues 102-115 (Greek key loop VI), variations in recognition by the mAbs may indicate different conformations in this loop. We have observed that the conformation of the peptide 92-122 (Fig. 4C, peak 9) , including the Greek key loop VI, is changeable depending on the solvents, such as water, saline (150 mM NaCl), and PBS, by CD measurements and that the peptide reacts with mAb N6 only when solved in PBS on ELISA.
2 Preliminary one-dimensional 1 H NMR spectroscopy of the peptide 92-122 was also performed by a Bruker DRX-800 spectrometer. Most of the NMR peaks derived from the aromatic and amide 1 H spins were observed in a narrow spectra range from 7.9 to 8.7 ppm. In addition, peaks from the aliphatic spins were crowded and were separated into several groups. These features of the 1 H spectra also suggest that the peptide 92-122 takes neither a typical secondary structure nor a rigid conformation. 3 Shipp et al. (38) have reported that comparison of dynamic properties between G93A and wild-type by NMR spectroscopy showed that G93A exhibits a higher mobility than wild type, particularly in loop III (residues 37-40), which is another short Greek key loop, and loop V (residues 89 -93). The increased mobility of the longer Greek key loop VI (residues 102-115) was not described in the NMR study. However, Greek key loop VI may also have property to move easily, because loop regions normally display greater mobility than residues involved in secondary structural elements (38) . Because the NMR study needs enough stability for analyzing all residues of the polypeptide at room temperature, the Greek key loop VI in G93A may be stable at the native state. On the other hand, the NMR study of A4V failed because degradation was found from the NMR spectra just a few days after purification (38) .
The Greek key loop VI contributes to the stability of Cu/Zn-SOD. In particular, Leu-106 and Ile-113 in the Greek key loop act to stabilize the ␤-barrel and dimer interface. The Leu-106 side chain points toward the protein core to create a "cork," which stabilizes the ␤-barrel structure through hydrophobic interactions (39) . The mutation from Cys-111 to Ser-111 (C111S) has an increased conformational stability resulting, in part, from the stronger side chain to main chain hydrogen bonds from the O ␥ of Ser-111 to the N of Ile-113 and the O of Leu-106 in the Greek key loop (10) . By contrast, the crystallographic structure of A4V showed that a mutation from Ala-4 to Val-4 causes the movement of the Leu-106 to cork out of the barrel, even though this A4V protein has the mutation from Cys-111 to Ser-111 (40) . The higher immunoreactivity of the mAbs against native A4V may indicate this loose shape of the Greek key loop VI. In the case of WT or C111S, the loop may change to the loose shape only after denaturation. Further studies on which shape of the Greek key loop VI reacts with each mAb will be needed.
Reduction by DTT caused the largest differences in recognition by mAbs between wild-type and FALS mutant SODs. As shown in Fig. 5 , the immunoreactivities of A4V, G37R, and G93A against all mAbs were drastically decreased when treated with DTT at concentrations above 1 mM, whereas those of WT, C111S, and H46R increased oppositely at the same concentration of DTT. CD analyses also showed that FALS mutant SODs are much more unstable to DTT treatment than WT and C111S (Fig. 9C ). Tiwari and Hayword (41) reported that, in the presence of disulfide-reducing agents, FALS mutant SODs were more susceptible than WT to aberrant migration during partially denaturing SDS-PAGE and to proteolytic digestion. A conserved internal disulfide bond between Cys-57 and Cys-146 also contributes to the stability of Cu/Zn-SOD. Cys-57 is located in the longest loop IV containing residues 49 -84 between ␤-sheet 6d and ␤-sheet 5e, which comprises part of the dimer interface and forms the zinc-binding site. Cys-146 is located in ␤-sheet 8h containing residues 145-152. A part in the ␤-sheet 8h is hydrogen bonding with Gly-114 and Arg-115 in the Greek key loop VI (9) . Therefore, the presence of DTT in coating buffer, pH 9.6, would induce the cleavage of the 3 T. Ikegami and N. Fujiwara, unpublished data. disulfide bond and cause disorder in loop IV, the ␤-sheet 8h, and the structure of the Greek key loop VI. However, even though the mutation sites are far from the Greek key loop VI and each mutation site is different, the question of why it is clearly different in terms of immunoreactivity against mAbs between wildtype Cu/Zn-SOD-like proteins (WT, C111S, and H46R) and typical FALS mutant SODs (A4V, G37R, and G93A) after DTT treatment remains unanswered. The reason for why H46R is included in the wild-type like SOD group is discussed below.
Because His-46 is one of the copper-ligand amino acids in Cu/Zn-SOD, the mutant enzyme, H46R, contains no copper and thus is SOD-inactive (4). However, the possibility must be considered that H46R is more stable than other typical FALS mutant SODs. Among FALS patients, the clinical progression is quite different from the mutations in the SOD1 gene. For H46R patients, the progression is extremely slow, with a mean survival of 16.8 years (42) . In contrast, the mean survival of G93A cases in one report was 2.2 years (43). Recently, Nagai et al. (44) established an H46R rat and a G93A rat. Even though the H46R SOD protein level in the H46R rat was much higher than that in the G93A rat, both the onset and the rate of progression of the disease in the H46R rat were much slower than those for the G93A rat (44) . We also observed that H46R has a longer half-life than the other FALS mutants (Fig. 1) (36) . Moreover, Niwa et al. (15) reported that ubiquitination of H46R by Dorfin, which is the likely ubiquitin ligase for FALS mutant SODs, was lower than other FALS mutant SODs. Recently, Miyazaki et al. (45) reported that NEDL1, a novel HECT-type ubiquitin ligase, also ubiquitinates FALS mutants and that the degree of ubiquitination of mutant SODs was dependent on the disease severity of FALS (A4V Ͼ G93A Ͼ H46R). These results also indicate that H46R is much more stable than other FALS mutant SODs in vivo. In contrast, the recombinant H46R protein is quite sensitive to DTT, SDS, and heat treatment (Fig. 9) . Several papers (41, 46) have also reported that H46R is less stable than other FALS mutants in vitro. Most interestingly, the immunoreactivities of H46R against the mAbs in Western blot and ELISA were similar to that of WT or C111S (Figs. 2, 3 , and 5-7). Therefore, local conformational changes monitored with mAbs will be useful for understanding the discrepancy between the instability of the H46R protein in vitro and the slower clinical progression of H46R patients.
There is accumulating evidence that FALS mutant SODs also tend to form aggregates under the destabilizing conditions (19 -22) , similar to other neurodegenerative disorders such as Alzheimer's, Parkinson's, Huntington's, and prion diseases. It is generally thought that aggregation or amyloid formation requires a conformational transition in a polypeptide chain from a native form to a mis-folded conformation in these diseases. In the case of prion disease, the conformational conversion of a normal ␣-helical rich cellular prion protein (PrP c ) to an abnormal and insoluble ␤-sheet rich form (PrP sc ) is a key event in the pathogenesis (47) . The structural rearrangement in the central portion (residues 90 -120) in the PrP c is associated with the conversion to the infectious conformer (25) . Thus the peculiar, subtle conformational change in the Greek key loop in FALS mutant SODs may also serve as a trigger for aggregation or amyloid formation. Moreover, if small change in FALS mutant SODs are recognized by ubiquitin ligase specific for FALS mutant SOD proteins, such as Dorfin or NEDL1, FALS mutant SODs would undergo a more rapid degradation in cells. To determine the significance of the alteration in the Greek key loop for FALS mutant SODs, further studies using various mAbs recognizing other regions and other mutant SODs are needed.
In the present study, we found different recognition by mAbs between wild-type and FALS mutant SODs under the denatured conditions, which suggests that different conformations are induced around the Greek key loop during the unfolding process. This new approach using mAbs will contribute to a better understanding of the molecular mechanism of the conformational perturbation of FALS mutant proteins, and may be of value in the development of a diagnosis and therapeutic agents for use in treating FALS.
